Research ArticleOriginal Article
Open Access
Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital
Ali A. Ruwayni, Eman E. AlObary and Khalid M. Alyahya
Saudi Medical Journal January 2024, 45 (1) 34-39; DOI: https://doi.org/10.15537/smj.2024.45.1.20230236
Ali A. Ruwayni
From the Department of Pharmaceutical Care (Ruwayni), Armed Forces Hospital, Jazan, and from the Department of Pharmaceutical Care (Ruwayni, AlObary, Alyahya), Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
PharmD, SSCIMPEman E. AlObary
From the Department of Pharmaceutical Care (Ruwayni), Armed Forces Hospital, Jazan, and from the Department of Pharmaceutical Care (Ruwayni, AlObary, Alyahya), Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
MScKhalid M. Alyahya
From the Department of Pharmaceutical Care (Ruwayni), Armed Forces Hospital, Jazan, and from the Department of Pharmaceutical Care (Ruwayni, AlObary, Alyahya), Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
PhD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital
Ali A. Ruwayni, Eman E. AlObary, Khalid M. Alyahya
Saudi Medical Journal Jan 2024, 45 (1) 34-39; DOI: 10.15537/smj.2024.45.1.20230236
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.